JP2018523092A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018523092A5 JP2018523092A5 JP2017557192A JP2017557192A JP2018523092A5 JP 2018523092 A5 JP2018523092 A5 JP 2018523092A5 JP 2017557192 A JP2017557192 A JP 2017557192A JP 2017557192 A JP2017557192 A JP 2017557192A JP 2018523092 A5 JP2018523092 A5 JP 2018523092A5
- Authority
- JP
- Japan
- Prior art keywords
- kda
- measuring
- sample
- tbi
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562157389P | 2015-05-05 | 2015-05-05 | |
| US62/157,389 | 2015-05-05 | ||
| PCT/US2016/031043 WO2016179426A1 (en) | 2015-05-05 | 2016-05-05 | Astrocyte traumatome and neurotrauma biomarkers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018523092A JP2018523092A (ja) | 2018-08-16 |
| JP2018523092A5 true JP2018523092A5 (enExample) | 2019-06-06 |
| JP6839854B2 JP6839854B2 (ja) | 2021-03-17 |
Family
ID=57218432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017557192A Active JP6839854B2 (ja) | 2015-05-05 | 2016-05-05 | 星状細胞トラウマトーム（ｔｒａｕｍａｔｏｍｅ）および神経外傷のバイオマーカー |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US10557859B2 (enExample) |
| EP (1) | EP3292414B1 (enExample) |
| JP (1) | JP6839854B2 (enExample) |
| CN (1) | CN107864671A (enExample) |
| ES (1) | ES2873509T3 (enExample) |
| IL (1) | IL255351A0 (enExample) |
| WO (1) | WO2016179426A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6839854B2 (ja) * | 2015-05-05 | 2021-03-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | 星状細胞トラウマトーム（ｔｒａｕｍａｔｏｍｅ）および神経外傷のバイオマーカー |
| US11709168B2 (en) * | 2017-05-23 | 2023-07-25 | Brainbox Solutions, Inc. | Biomarker levels and neuroimaging for detecting, monitoring and treating brain injury or trauma |
| JP2021503610A (ja) * | 2017-11-16 | 2021-02-12 | ブレインボックス ソルーションズ、インコーポレイテッドＢｒａｉｎｂｏｘ Ｓｏｌｕｔｉｏｎｓ， Ｉｎｃ． | 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法 |
| AU2018395255B2 (en) | 2017-12-29 | 2025-02-20 | Abbott Laboratories | Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury |
| EP4053559A1 (en) * | 2021-03-01 | 2022-09-07 | Consorcio Centro de Investigación Biomédica en Red, M.P. (CIBER) | Methods for the measurement of protein c and activated protein c |
| WO2026068747A1 (en) * | 2024-09-26 | 2026-04-02 | Centre Hospitalier Universitaire Vaudois (C.H.U.V.) | Astrocytic phosphoprotein (pea-15) for use in the treatment and/or prevention of a neuronal disorder |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8492107B2 (en) | 2004-04-15 | 2013-07-23 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
| GB0414798D0 (en) * | 2004-07-01 | 2004-08-04 | Paradigm Therapeutics Ltd | Receptor |
| WO2007136617A2 (en) * | 2006-05-18 | 2007-11-29 | Walter Reed Army Institute Of Research (Wrair) | Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury |
| EP2245466A2 (en) * | 2008-02-04 | 2010-11-03 | Banyan Biomarkers, Inc. | Process to diagnose or treat brain injury |
| EP3355059A3 (en) | 2009-06-19 | 2018-09-26 | Banyan Biomarkers, Inc. | Biomarker assay of neurological condition |
| KR101211280B1 (ko) * | 2010-03-26 | 2012-12-11 | 가톨릭대학교 산학협력단 | 신규한 뇌손상 질환 진단용 마커 및 이의 용도 |
| WO2011147981A2 (en) | 2010-05-28 | 2011-12-01 | Mind-Nrg Sa | Neuregulin isoforms, neuregulin polypeptides and uses thereof |
| EP2628013B1 (en) | 2010-10-14 | 2019-06-12 | The Johns Hopkins University | Biomarkers of brain injury |
| CN106461645A (zh) | 2014-04-07 | 2017-02-22 | 铁马诊断公司 | 外伤性脑损伤和神经退行性生物标记物、方法和系统 |
| US20170266257A1 (en) | 2014-09-25 | 2017-09-21 | Oxeia Biopharmaceuticals, Inc. | Methods of treating traumatic brain injury |
| JP6839854B2 (ja) * | 2015-05-05 | 2021-03-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | 星状細胞トラウマトーム（ｔｒａｕｍａｔｏｍｅ）および神経外傷のバイオマーカー |
-
2016
- 2016-05-05 JP JP2017557192A patent/JP6839854B2/ja active Active
- 2016-05-05 ES ES16790108T patent/ES2873509T3/es active Active
- 2016-05-05 US US15/570,982 patent/US10557859B2/en active Active
- 2016-05-05 CN CN201680032940.6A patent/CN107864671A/zh active Pending
- 2016-05-05 EP EP16790108.1A patent/EP3292414B1/en active Active
- 2016-05-05 WO PCT/US2016/031043 patent/WO2016179426A1/en not_active Ceased
-
2017
- 2017-10-31 IL IL255351A patent/IL255351A0/en unknown
-
2019
- 2019-12-16 US US16/716,095 patent/US11249094B2/en active Active
-
2022
- 2022-01-06 US US17/647,289 patent/US12339289B2/en active Active
-
2025
- 2025-05-02 US US19/197,759 patent/US20260110699A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11360103B2 (en) | Alpha-synuclein detection assay and method for diagnosing alpha- synucleinopathies | |
| DK2341350T3 (en) | DIAGNOSTIC PROCEDURE FOR BRAKE INJURY-RELATED DISORDERS BASED ON DJ-1 DETECTION | |
| JP2016533499A5 (enExample) | ||
| US11371991B2 (en) | Diagnosis of a neuroautoimmune disease | |
| JP2016105097A5 (enExample) | ||
| US20140234877A1 (en) | Method for detecting a beta-specific antibodies in a biological sample | |
| JP2018510343A5 (enExample) | ||
| ES2788389T3 (es) | Ensayo mejorado para el diagnóstico de alergia al cacahuete | |
| JP2013529292A5 (enExample) | ||
| JP2021503610A5 (enExample) | ||
| AU2025202839A1 (en) | Method for detecting inflammasome proteins as biomarkers of neurological disorders | |
| KR20150140657A (ko) | 자간전증의 진단을 위한 방법 및 조성물 | |
| Mello | Potential contribution of ELISA and LFI assays to assessment of the oxidative stress condition based on 8-oxodG biomarker | |
| JP2016526167A5 (enExample) | ||
| JP2017524933A5 (enExample) | ||
| EA025107B1 (ru) | Способ диагностирования болезни альцгеймера, нейродегенерации при синдроме дауна или легкого когнитивного нарушения у субъекта (варианты) и набор для осуществления способа | |
| Ballard et al. | α-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies | |
| JP7693173B2 (ja) | マカダミアナッツアレルゲン特異的ＩｇＥを検出するための方法、マカダミアナッツアレルギー診断用体外診断薬、マカダミアナッツアレルゲン特異的ＩｇＥ検出用キット、およびマカダミアナッツアレルゲンの検出方法 | |
| WO2014080063A1 (es) | Proteína recombinante y usos en el diagnóstico de la esclerosis múltiple | |
| CN108431032B (zh) | 纤维蛋白原捕捉剂检测ciz1 b变体的用途 | |
| DK1664795T3 (en) | DIAGNOSTIC PROCEDURE FOR Brain Injury-Related Disorders | |
| CN102713624B (zh) | 抗Ku86自身抗体的免疫测定方法、其中使用的试剂盒、及使用其的原发性肝细胞癌的判断方法 | |
| ES2992145T3 (es) | Método para predecir o pronosticar la respuesta al tratamiento de la esclerosis múltiple con interferón beta | |
| CA3029204C (en) | Alpha-synuclein detection assay and method for diagnosing alpha-synucleinopathies | |
| RU2627653C1 (ru) | Способ контроля эффективности сорбции липополисахарида при проведении селективной липополисахаридной гемосорбции |